1581434683 8971


Sanofi Pasteur A subsidiary of French pharmaceutical giant Sanofi said on Wednesday that it will use its previous development work to tackle SARS Development potential For COVID-19 (disease).


As part of the plan, the company said it will work with the United States Department of and Human Services' Biomedical Advanced Research and Development Agency (BARDA).


"Tackling the latest global threats There will be cooperation, which is why we are working with BARDA to rapidly advance potential vaccine candidates, "said David Loew, global head of Sanofi Vaccine, in a statement.


He added that while the company provides its expertise where possible, it believes that cooperation with BARDA may provide the most meaningful results in protecting the public from the latest outbreaks.


COVID-19 is a respiratory disease caused by novelty

Ranch
At the end of 2002, SARS (Severe Acute Respiratory Syndrome) coronavirus appeared, and then disappeared in 2004.

Ranch
Sanofi plans to further study advanced vaccine candidates for preclinical SARS that can prevent COVID-19.

Ranch
The company said it will use its recombinant DNA platform to produce new coronavirus vaccine candidates for 2019.

Ranch
Recombinant technology produces precise genetic matches with proteins on the surface of the virus.

Ranch
"Emerging global threats such as the new coronavirus 2019 need to respond quickly," said Rick A Bright, director of BARDA.

Ranch
He further said: "By expanding our And using a licensed recombinant vaccine platform, we hope to accelerate the development of candidate vaccines to defend against new viruses.

See also  Xiaomi’s Smarter Life in India 2022 today: How to watch the live broadcast, Xiaomi Notebook, Xiaomi TV 5X, more announcements are expected

Ranch
In December 2019, Sanofi also reached an agreement with BARDA to a facility in the United States to sustainably produce adjuvant recombinant vaccines for influenza pandemics, and is based on the technology platform COVID- 19 plans.

Ranch
To date, approximately 2,000 people (mainly in mainland China) have of illness due to a coronavirus outbreak.